Detalhe da pesquisa
1.
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy.
Haematologica
; 108(2): 444-456, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950534
2.
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 19(3): 398-404, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078786
3.
Comparison of single copy genebased duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19directed CAR T cells in treated patients.
Int J Oncol
; 60(5)2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294040
4.
Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting.
Blood Adv
; 5(11): 2523-2527, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100900
5.
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.
Leukemia
; 33(1): 99-109, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907810
6.
Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.
Leuk Lymphoma
; 51(10): 1837-43, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20849383
7.
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.
Exp Hematol
; 38(12): 1261-71, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20851159
8.
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
Exp Hematol
; 37(7): 791-8, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19487069